+49 30 648 35 164 service@chameleon-pharma.com

Italy

Boats on the canal in Venise during sunset

Featured image: Photo by Henrique Ferreira on Unsplash

Italy: a strong pharma and self-medication market in Europe

Italy’s investment in R&D pushed them to rank amongst the strongest consumer health and pharma markets in Europe and is setting the tone for its development over the next few years. 

Italy is not only great for pizza and pasta; it also boasts a large OTC and pharma mar­ket. Together with Germany, it is a European leader whose exports have grown by 168% from 2010 to 2020. The self-medication and Rx market should reach a worth of USD 34,07 billion in value in 2035, according to our estimation.

In recent years, the country has invested a lot of money in research and devel­op­ment. € 1.6 billion were investments, of which over €700 were dedicated to clinical trials, generating new knowledge and skills. Another €1,4 Billion were invested for production purposes. 

Italy got first place in the EU (and fourth in the world)  for scientific publications on Covid-19 which at least 75% were open access publications. 

After the pandemic, the market is having a digital transformation. 92% of the OTC and pharma companies in 2020 maintained or increased investment in digital technologies and 222 telemedicine initiatives were implemented between 2020 and 2021, many on platforms for cooperation developed in association with companies.   

The Italian OTC and pharma market employs 66,500 people and 146,000 in allied industries. Employment has risen at a higher rate than in other sectors thanks to the industry dynamism, and its sustainable openness for growth and development.

Almost half of the population in Italy take medicinal products in Italy and they use 19% of their per capita spending on public consumer healthcare and pharma products, because of the availability and access to new and existing medicines. 

The OTC and Rx industry in Italy is continuously growing and has the opportunity for expanding as the industry is transforming and shaping along with the market requirement and by implementing good business policies. If you want to take advantage of this growing market, Chameleon Pharma Consulting Group is here to assist you!

The Italian OTC and pharma market in 2035

USD 34,1 Billion

OTC and pharma market size, ex-factory

1-2%

OTC and pharma market growth

Italy in numbers

Total population

Male/Female

Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market?

 

We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.

Our services

i

International Strategy & Analysis

Licensing and
M&A

International Business & Market Entry

Pharma Regulatory & Registration

U

Product Potential & Country Analysis

Pharma Executive
Search

International Company Partner Identification

Market Reports and Analysis